A5017597768- Health Systems, Economic Evaluations, Quality of Life
- Global Health Care Issues
- Global Maternal and Child Health
- Healthcare Policy and Management
- Healthcare Systems and Reforms
- Healthcare cost, quality, practices
- Economic and Environmental Valuation
- HIV/AIDS Impact and Responses
- HIV/AIDS Research and Interventions
- Health Policy Implementation Science
- Global Health Workforce Issues
- Mental Health and Patient Involvement
- Global Cancer Incidence and Screening
- HIV/AIDS drug development and treatment
- Sex work and related issues
- Socioeconomic Development in MENA
- Leprosy Research and Treatment
- Global Public Health Policies and Epidemiology
- Pharmaceutical Economics and Policy
University of York
2015-2025
Inserm
2018
Medical Research Council
2018
Economic and Social Research Council
2018
National Institute for Health Research
2018
PENTA Foundation
2018
European Commission
2018
The economic evaluation of healthcare interventions requires an assessment whether the improvement in health outcomes they offer exceeds that would have been possible if additional resources required had, instead, made available for other activities. Therefore, some these opportunity costs is best use to be healthcare. This paper provides a framework generating country-specific estimates cost per disability-adjusted life year (DALY) averted ‘thresholds’ reflect costs. We apply estimated...
<ns4:p>Public payers around the world are increasingly using cost-effectiveness thresholds (CETs) to assess value-for-money of an intervention and make coverage decisions. However, there is still much confusion about meaning uses CET, how it should be calculated, what constitutes adequate evidence base for its formulation. One widely referenced used threshold in last decade has been 1-3 GDP per capita, which often attributed Commission on Macroeconomics WHO guidelines Choosing Interventions...
Malawi, like many low-income and middle-income countries, has used health benefits packages (HBPs) to allocate scarce resources key healthcare interventions. With no widely accepted method for their development, HBPs often promise more than can be delivered, given available resources. An analytical framework is developed guide the design of that identify potential value including implementing different It provides a basis informing meaningful discussions between governments, donors other...
Introduction Leprosy is a curable disease, treated by multidrug therapy. However, patients are often left with neuropathic damage leading to lifelong vulnerability ulcers. Quantifying the value of interventions improve ulcer healing challenging as data on health impact plantar ulcers scarce, especially in low- and middle-income countries. We aim quantify patients’ health-related quality life (HRQoL) using methods which can inform decisions about effectiveness cost-effectiveness alternative...
Low- and middle-income countries (LMICs) face difficult decisions about which health care interventions are worthwhile given existing constraints on expenditure. Decisions require some assessment of the opportunity costs proposed investments, i.e., a ‘supply side’ cost-effectiveness threshold (CET) that represents likely effects changes in expenditure. This paper provides framework for generating country-level CETs using published estimates mortality effect Two different estimation...
Introduction Estimating the value of providing effective healthcare interventions in a country requires an assessment whether improvement health outcomes they offer exceeds that would have been possible if resources required had, instead, made available for other activities country. This potential alternative use same represents opportunity cost intervention. Without such assessments, there is danger blanket recommendations by international organisations will lead to adoption are not some...
Saudi Arabia's Vision 2030 aims to reform health care across the Kingdom, with technology assessment being adopted as one tool promising improve efficiency which resources are used. An understanding of opportunity costs reimbursement decisions is key fulfilling this promise and can be used inform a cost-effectiveness threshold. This paper first provide range estimates using existing evidence extrapolated context Arabia.
The primary focus of this paper is to offer guidance on the analysis time streams effects that a project may have so they can be discounted appropriately. This requires framework identifies common parameters need assessed, whether conducting cost-effectiveness or benefit-cost analysis. quantification and conversion different into their equivalent health, health care cost consumption avoids embedding multiple arguments in discounting policies. helps identify where are likely differ particular...
Current health economic analysis guidelines emphasize the importance of using nationally appropriate cost and valuation inputs. However, some countries lack national data, analyses focus on interventions with costs benefits at regional or global scales.Recognizing need for better estimates values application these levels than those used in past, we characterize population-weighted dollar per disability-adjusted life year (DALY) averted by World Bank Income Level based available marginal...
Economic evaluation of health-related projects requires principles and methods to address the various trade-offs that need be made between costs benefits, across sectors social objectives, over time. Existing guidelines for economic in low- middle-income countries embed implicit assumptions about expected changes marginal cost per unit health produced by healthcare sector, consumption value appropriate discount rates consumption. Separating these parameters out estimates each country time,...
Setting out a health benefits package (HBP) of interventions to be prioritised for funding is an important step towards achieving universal coverage in low and middle income countries. The 3rd version the Disease Control Priorities (DCP3) database, other similar databases, aim establishing single point reference ("one stop shop") cost effectiveness evidence inform HBP design policy making. We reflect upon our experiences using DCP3 offer suggestions improving future reporting...
Universal Health Coverage (UHC) has become a key goal of health policy in many developing countries. However, implementing UHC poses tough choices about: what treatments to provide (the depth coverage); proportion the population breadth at price patients height coverage). This paper uses theoretical mathematical programming model derive analytically optimal balance between range services provided and covered under UHC, using general principles cost-effectiveness analysis. In contrast most...